London · Delayed Price · Currency is GBP · Price in GBX Tate & Lyle Earnings Call Transcripts
Fiscal Year 2026
-
Q3 results were in line with expectations, with muted demand leading to a 2% pro forma revenue decline, but reported revenue rose 15% due to the CP Kelco acquisition. Strategic investments and strong customer engagement in innovation and fiber fortification support future growth.
-
Integration of CP Kelco is driving strong customer engagement and a robust new business pipeline, but near-term performance is impacted by weak market demand, especially in North America. Revenue and EBITDA are expected to decline slightly for the year, with cost and revenue synergies from the acquisition tracking ahead of plan.
-
Integration with CP Kelco is driving cross-selling and margin improvements, but H1 revenue and EBITDA are expected to decline due to demand softness, especially in North America. Tariffs and economic volatility remain key risks, while productivity and cash conversion are ongoing priorities.
Fiscal Year 2025
-
A specialty food solutions leader has completed its transformation, integrating CP Kelco to enhance its portfolio and global reach. With a strong innovation pipeline, robust financials, and a focus on health, sustainability, and reformulation, it targets revenue growth at the higher end of 4%-6% per year.
-
Completed transformation into a specialty food and beverage solutions business, delivering robust EBITDA growth and strong cash flow despite a 5% revenue decline. Integration of CP Kelco is progressing well, with cost and revenue synergies on track and a focus on accelerating top-line growth.
-
Solid Q3 performance with volume and EBITDA growth, despite revenue decline from input cost deflation. CP Kelco integration is on track, supporting innovation and synergy targets. Market demand remains muted, but contract renewals and a strong innovation pipeline position the business for future growth.
-
Strong H1 results with 6% EBITDA growth, robust cash flow, and margin expansion, despite a 7% revenue decline due to input cost deflation. The CP Kelco combination and innovation investments position the business for accelerated growth, with full-year guidance for 4–7% EBITDA growth reaffirmed.
-
Strong H1 performance with 6% volume and EBITDA growth, robust cash generation, and margin expansion, despite a 7% revenue decline from input cost deflation. Strategic transformation advanced with the Primient sale and CP Kelco combination, supporting long-term growth.
Fiscal Year 2024
-
The acquisition accelerates the growth strategy by combining complementary strengths in specialty food and beverage solutions, targeting enhanced margins, cost and revenue synergies, and expansion into new markets and adjacencies. Integration is expected to be smooth, with no major regulatory hurdles.
-
The acquisition combines two complementary specialty ingredient businesses, creating a global leader in mouthfeel and expanding offerings in key categories. The $1.8 billion deal targets significant cost and revenue synergies, with completion expected in Q4 2024.